Literature DB >> 10204840

Cleidocranial dysplasia: clinical and molecular genetics.

S Mundlos1.   

Abstract

Cleidocranial dysplasia (CCD) (MIM 119600) is an autosomal dominant skeletal dysplasia characterised by abnormal clavicles, patent sutures and fontanelles, supernumerary teeth, short stature, and a variety of other skeletal changes. The disease gene has been mapped to chromosome 6p21 within a region containing CBFA1, a member of the runt family of transcription factors. Mutations in the CBFA1 gene that presumably lead to synthesis of an inactive gene product were identified in patients with CCD. The function of CBFA1 during skeletal development was further elucidated by the generation of mutated mice in which the Cbfa1 gene locus was targeted. Loss of one Cbfa1 allele (+/-) leads to a phenotype very similar to human CCD, featuring hypoplasia of the clavicles and patent fontanelles. Loss of both alleles (-/-) leads to a complete absence of bone owing to a lack of osteoblast differentiation. These studies show that haploinsufficiency of CBFA1 causes the CCD phenotype. CBFA1 controls differentiation of precursor cells into osteoblasts and is thus essential for membranous as well as endochondral bone formation.

Entities:  

Mesh:

Year:  1999        PMID: 10204840      PMCID: PMC1734317     

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  43 in total

1.  Cleidocranial dysostosis.

Authors:  E J LEVIN; H SONNENSCHEIN
Journal:  N Y State J Med       Date:  1963-05-15

2.  Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia.

Authors:  B Lee; K Thirunavukkarasu; L Zhou; L Pastore; A Baldini; J Hecht; V Geoffroy; P Ducy; G Karsenty
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

3.  Cleidocranial dysostosis.

Authors:  W R COLE; S LEVIN
Journal:  Br J Radiol       Date:  1951-10       Impact factor: 3.039

4.  Osteo-dental dysplasia (cleido-cranial dysostosis); the "Arnold head".

Authors:  W P U JACKSON
Journal:  Acta Med Scand       Date:  1951

5.  Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy.

Authors:  B Brais; J P Bouchard; Y G Xie; D L Rochefort; N Chrétien; F M Tomé; R G Lafrenière; J M Rommens; E Uyama; O Nohira; S Blumen; A D Korczyn; P Heutink; J Mathieu; A Duranceau; F Codère; M Fardeau; G A Rouleau; A D Korcyn
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

6.  Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia.

Authors:  S Mundlos; F Otto; C Mundlos; J B Mulliken; A S Aylsworth; S Albright; D Lindhout; W G Cole; W Henn; J H Knoll; M J Owen; R Mertelsmann; B U Zabel; B R Olsen
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

7.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

8.  Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation.

Authors:  P Ducy; R Zhang; V Geoffroy; A L Ridall; G Karsenty
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

9.  [Familial cleidocranial dysostosis].

Authors:  B Kempfle
Journal:  Dtsch Zahnarztl Z       Date:  1965-12-01

10.  Mouse clavicular development: analysis of wild-type and cleidocranial dysplasia mutant mice.

Authors:  L F Huang; N Fukai; P B Selby; B R Olsen; S Mundlos
Journal:  Dev Dyn       Date:  1997-09       Impact factor: 3.780

View more
  111 in total

Review 1.  Development and evolution occlude: evolution of development in mammalian teeth.

Authors:  P D Polly
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

Review 2.  Genetic disorders of the skeleton: a developmental approach.

Authors:  Uwe Kornak; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2003-07-31       Impact factor: 11.025

3.  Modified U1 snRNA suppresses expression of a targeted endogenous RNA by inhibiting polyadenylation of the transcript.

Authors:  Peng Liu; Mark Kronenberg; Xi Jiang; David Rowe
Journal:  Nucleic Acids Res       Date:  2004-03-03       Impact factor: 16.971

4.  Osteoblast lineage cells expressing high levels of Runx2 enhance hematopoietic progenitor cell proliferation and function.

Authors:  Brahmananda R Chitteti; Ying-Hua Cheng; Drew A Streicher; Sonia Rodriguez-Rodriguez; Nadia Carlesso; Edward F Srour; Melissa A Kacena
Journal:  J Cell Biochem       Date:  2010-10-01       Impact factor: 4.429

5.  Cleidocranial dysostosis.

Authors:  Riddhi DasGupta; Felix K Jebasingh; Hesarghatta Shyamasunder Asha; Nihal Thomas
Journal:  BMJ Case Rep       Date:  2015-08-26

6.  Cleidocranial Dysplasia with Normal Clavicles: A Report of a Novel Genotype and a Review of Seven Previous Cases.

Authors:  Ankur Singh; Mridula Goswami; Gaurav Pradhan; Min-Su Han; Je-Yong Choi; Seema Kapoor
Journal:  Mol Syndromol       Date:  2015-02-28

7.  Identification of USF2 as a key regulator of Runx2 expression in mouse pluripotent mesenchymal D1 cells.

Authors:  Chihuei Wang; Grace Lee; Wayne Hsu; Ching-Hua Yeh; Mei-Ling Ho; Gwo-Jaw Wang
Journal:  Mol Cell Biochem       Date:  2006-06-20       Impact factor: 3.396

8.  Dental treatment strategies in a 40-year-old patient with cleidocranial dysplasia.

Authors:  Aneta Olszewska
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

9.  [Immunohistochemical study on collagen I content in the gingiva in cleidocranial dysplasia].

Authors:  Tobias Ach; Uwe Baumert; Christian Morsczeck; Regine Dahse; Torsten Eugen Reichert; Oliver Driemel
Journal:  Mund Kiefer Gesichtschir       Date:  2007-12

10.  FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization.

Authors:  Ok-Jin Park; Hyun-Jung Kim; Kyung-Mi Woo; Jeong-Hwa Baek; Hyun-Mo Ryoo
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.